DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Varenhorst C, James S, Erlinge D. et al.
Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease.
Eur Heart J 2009;
30: 1744-1752.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.